A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
The purpose of this study is to evaluate the safety, tolerability, and efficacy of mavacamten compared with placebo in participants with symptomatic non-obstructive hypertrophic cardiomyopathy (nHCM).
Inclusion Criteria
Exclusion Criteria
Ashkelon, Tel Aviv 7830604, Israel
Himeji-Shi, Hyōgo 672-8044, Japan
Nankoku-shi, Kochi 783-8505, Japan
Takatsuki-Shi, Osaka 569-8686, Japan
Bunkyo-ku, Tokyo 1138603, Japan
Chuo-Ku, Tokyo 104-0044, Japan
Itabashi-Ku, Tokyo 173-0003, Japan
Koto-Ku, Tokyo 135-0061, Japan
Shinjuku-ku, Tokyo 160-8582, Japan
Shinjuku-ku, Tokyo 162-8666, Japan
Lørenskog, 1478, Norway
Lódz, 93-338, Poland